4.7 Article

Anti-Incretin Gut Features Induced by Feed Supplementation with Alpha-Amylase: Studies on EPI Pigs

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

The expanding incretin universe: from basic biology to clinical translation

Daniel J. Drucker et al.

Summary: Incretin hormones, such as GIP and GLP-1, play a crucial role in regulating insulin secretion and glucagon secretion. The receptors for these hormones are not only found in the pancreas but also in various other organs, suggesting a wide range of actions. The therapeutic potential of GIP and GLP-1 in treating type 2 diabetes and obesity is currently being explored.

DIABETOLOGIA (2023)

Review Endocrinology & Metabolism

Hypothesis that alpha-amylase evokes regulatory mechanisms originating in the pancreas, gut and circulation, which govern glucose/insulin homeostasis

Stefan G. Pierzynowski et al.

Summary: The anti-incretin theory suggests the existence of anti-incretin substances that can prevent type 2 diabetes through certain methods used in bariatric surgery. Our research has found that alpha-amylase may serve as an anti-incretin. Additionally, alpha-amylase inhibits the appearance of dietary glucose in the blood, reducing the glucose peak. Clinical observations have also shown that individuals with high blood alpha-amylase concentrations are less likely to be obese and develop type 2 diabetes.

WORLD JOURNAL OF DIABETES (2023)

Article Gastroenterology & Hepatology

Low serum pancreatic amylase levels as a novel latent risk factor for colorectal adenoma in non-alcohol drinkers

Yu Sasaki et al.

Summary: The study found an association between non-alcoholic fatty liver disease and colorectal cancer and adenoma, but the relationship with pancreatic disease is unclear. Low serum pancreatic amylase levels may be an independent risk factor for CRA.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Biotechnology & Applied Microbiology

Alpha-Amylase Inhibits Cell Proliferation and Glucose Uptake in Human Neuroblastoma Cell Lines

Kateryna Pierzynowska et al.

Summary: The article describes a study on the effects of α-amylase on human neuroblastoma cells. The research shows that α-amylase can inhibit cell proliferation and directly impact glucose uptake, suggesting its potential as an anticancer agent for neuroblastoma treatment.

BIOMED RESEARCH INTERNATIONAL (2022)

Article Agriculture, Dairy & Animal Science

Effects of exogenous α-(1,4)-amylase on the utilisation of corn starch and glucose metabolism in broiler chickens

H. Zhou et al.

Summary: This study found that excessive addition of exogenous alpha-(1,4)-amylase was not beneficial for the utilisation of starch in broiler chickens, and may negatively impact the growth performance of broiler chickens.

ANIMAL (2021)

Article Endocrinology & Metabolism

Association of Serum Amylase Activity and the Copy Number Variation of AMY1/2A/2B with Metabolic Syndrome in Chinese Adults

Fangjie Zhan et al.

Diabetes Metabolic Syndrome and Obesity-Targets and Therapy (2021)

Editorial Material Medicine, General & Internal

Metabolically Healthy Obesity Redefined

Ayana K. April-Sanders et al.

JAMA NETWORK OPEN (2021)

Article Cell Biology

Neuronal α-amylase is important for neuronal activity and glycogenolysis and reduces in presence of amyloid beta pathology

Elin Byman et al.

Summary: Recent studies suggest that neuronal alpha-amylase plays a crucial role in memory formation by degrading glycogen. Alpha-amylase deficiency in Alzheimer's disease patients may contribute to disrupted memory formation. The loss of alpha-amylase, induced by Aβ pathology, may be an underlying factor in impaired memory formation seen in AD patients.

AGING CELL (2021)

Article Biochemistry & Molecular Biology

α-Amylase expressed in human small intestinal epithelial cells is essential for cell proliferation and differentiation

Kimie Date et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Review Endocrinology & Metabolism

Low serum amylase, lipase, and trypsin as biomarkers of metabolic disorders: A systematic review and meta-analysis

Juyeon Ko et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2020)

Review Toxicology

Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic

Donna L. Mendrick et al.

TOXICOLOGICAL SCIENCES (2018)

Article Clinical Neurology

Brain alpha-amylase: a novel energy regulator important in Alzheimer disease?

Elin Byman et al.

BRAIN PATHOLOGY (2018)

Review Endocrinology & Metabolism

The Origin and Understanding of the Incretin Concept

Jens F. Rehfeld

FRONTIERS IN ENDOCRINOLOGY (2018)

Review Endocrinology & Metabolism

Human amylase gene copy number variation as a determinant of metabolic state

Patrick J. D. Elder et al.

EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2018)

Review Endocrinology & Metabolism

Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation

Kei Nakajima

WORLD JOURNAL OF DIABETES (2016)

Editorial Material Endocrinology & Metabolism

Is the Gut the Sweet Spot for the Treatment of Diabetes?

Francesco Rubino et al.

DIABETES (2014)

Article Endocrinology & Metabolism

Gastric Bypass Improves b-Cell Function and Increases b-Cell Mass in a Porcine Model

Andreas Lindqvist et al.

DIABETES (2014)

Article Genetics & Heredity

Low copy number of the salivary amylase gene predisposes to obesity

Mario Falchi et al.

NATURE GENETICS (2014)

Article Endocrinology & Metabolism

Is Type 2 Diabetes an Operable Intestinal Disease? A provocative yet reasonable hypothesis

Francesco Rubino

DIABETES CARE (2008)

Review Surgery

Potential of surgery for curing type 2 diabetes mellitus

F Rubino et al.

ANNALS OF SURGERY (2002)